Description générale
Ceftriaxone is a third-generation cephalosporin.
INN
Ceftriaxone
Codes ATC
Type de médicament
Chemical agent
Groupes d'antibiotiques
Historique des statuts LME
Ajouté pour la première fois en 1995
(TRS
867)
pour
Bacterial infection of unspecified site
Modifié en 2017
(TRS
1006)
pour
Bacterial meningitis
Modifié en 2017
(TRS
1006)
pour
Osteomyelitis or osteitis
Modifié en 2017
(TRS
1006)
pour
Bacterial infection of joint
Modifié en 2017
(TRS
1006)
pour
Sepsis without septic shock
Modifié en 2017
(TRS
1006)
pour
Infectious gastroenteritis or colitis without specification of infectious agent
Modifié en 2017
(TRS
1006)
pour
Gonococcal infection
Modifié en 2017
(TRS
1006)
pour
Peritoneal abscess
Modifié en 2017
(TRS
1006)
pour
Peritonitis
Retiré en 2017
(TRS
1006)
pour
Bacterial infection of unspecified site
Ajouté en 2017
(TRS
1006)
pour
Bacterial pneumonia
Modifié en 2017
(TRS
1006)
pour
Other specified pneumonia
Modifié en 2017
(TRS
1006)
pour
Acute pyelonephritis
Modifié en 2017
(TRS
1006)
pour
Inflammatory or other diseases of prostate
Modifié en 2019
(TRS
1021)
pour
Typhoid fever
Modifié en 2019
(TRS
1021)
pour
Paratyphoid fever
Modifié en 2021
(TRS
1035)
pour
Endophthalmitis
Modifié en 2023
(TRS
1049)
pour
Necrotising fasciitis
Modifié en 2025
(TRS
1064)
pour
Bacterial meningitis
Wikipédia
DrugBank
Recommandations
Section
Watch group antibiotics
- Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
- Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
- Parenteral > General injections > unspecified: 2 g in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 250 mg in vial powder for injection (as sodium salt)
- Parenteral > General injections > unspecified: 2 g in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 250 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
- Parenteral > General injections > unspecified: 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 250 mg in vial powder for injection (as sodium salt)
- Parenteral > General injections > unspecified: 500 mg in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 250 mg in vial powder for injection (as sodium salt)
- Parenteral > General injections > unspecified: 1 g in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 250 mg in vial powder for injection (as sodium salt)
- Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt)
- Parenteral > Locoregional injections > Intravitreal: 2 g in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 250 mg in vial powder for injection (as sodium salt)
- Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial
Indications
Premier choix
Bacterial pneumonia (Community-acquired pneumonia - severe) Bacterial pneumonia (Community-acquired pneumonia - severe) [children] Bacterial meningitis Peritonitis (mild-moderate) Peritonitis (severe) Gonococcal infection Other specified pneumonia (Hospital-acquired pneumonia) Acute pyelonephritis (severe) Inflammatory or other diseases of prostate (severe) Peritoneal abscess (mild-moderate) Peritoneal abscess (severe) Typhoid fever Paratyphoid fever Endophthalmitis
Autres indications
Section
Medicines for bacterial central nervous system infections
- Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)